Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma

BACKGROUND: Toceranib phosphate (Palladia) has a reported objective response rate of 25% in both canine apocrine gland anal sac adenocarcinoma (AGASACA) and thyroid carcinoma (TC), with stable disease occurring in an additional 50-60% of dogs. The basis for the observed responses to toceranib is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Urie, Bridget K, Russell, Duncan S, Kisseberth, William C, London, Cheryl A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542001/
https://www.ncbi.nlm.nih.gov/pubmed/22630170
http://dx.doi.org/10.1186/1746-6148-8-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542001/
https://www.ncbi.nlm.nih.gov/pubmed/22630170
http://dx.doi.org/10.1186/1746-6148-8-67

Ejemplares similares